Navigation Links
National Jewish Health, the Nation's Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
Date:5/1/2012

DENVER and DESOTO, Kan., May 1, 2012 /PRNewswire/ -- National Jewish Health (NJH), the # 1 respiratory hospital in the United States, today announces the initiation of a lung cancer screening trial that evaluates the use of a blood test, known as EarlyCDT-Lung, in conjunction with low dose CT to determine the clinical value added by the blood test when compared to CT screening alone, which was shown recently by the National Lung Screening Trial (NLST) (1) in the U.S. to reduce mortality by 20%.  James Jett, M.D., a National Jewish Health lung cancer expert, will serve as the Principal Investigator for the study.  Patient recruitment for the trial begins immediately.  Those interested in participating can call 303.398.1911. (See eligibility requirements below – How to take part in the trial.)

The National Jewish Health trial will be a prospective trial combining low dose (radiation) CT screening and the EarlyCDT-Lung blood test to determine if the two together are better than either test alone when used in screening high risk individuals for lung cancer.  Previous studies that led to the development and launch of the EarlyCDT-Lung blood test as a risk assessment tool for lung cancer were case control trials.

"Having watched the progress of the EarlyCDT-Lung test with interest over the past few years I am excited to be the Principal Investigator for the new study between CEAC (The Centre of Excellence for Autoimmunity in Cancer – Nottingham University, UK) and National Jewish Health being announced today. I reviewed the EarlyCDT-Lung validation data before launch and I also reviewed the performance of the first 1,000 commercial tests in the USA. These showed that the test performed as expected in the clinical setting and I presented this analysis at the World Lung Cancer Conference in Amsterdam last year. I believe
'/>"/>

SOURCE Oncimmune
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
2. Chindex International, Inc. to Report First Quarter 2012 Financial Results
3. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
4. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
5. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
6. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
7. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
8. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
9. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 Itamar ... a private investment in public equity (PIPE) deal, in ... million in Itamar Medical.   Through this ... of Itamar Medical and will work closely with the ... According to the investment agreement, Itamar Medical will ...
(Date:8/27/2015)... Aug. 27, 2015  Zimmer Biomet Holdings, Inc. (NYSE ... announced that it will be participating in the Goldman ... Goldman Sachs offices in London ... Company Founded in 1927 and headquartered in ... leader in musculoskeletal healthcare.  We design, manufacture and market ...
(Date:8/27/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced that it will ... ending June 30, 2015 on Friday, September 4, 2015. ... business update conference call and live webcast for investors, ...
Breaking Medicine Technology:Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 2DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 3
... Oct. 14 ZyStor Therapeutics, Inc., a biotechnology company ... the treatment of Lysosomal Storage Diseases using the Company,s ... it has received clearance from the U. S. Food ... for its first drug candidate, ZC-701, an enzyme replacement ...
... Company (NYSE: LLY ) today announced the sale ... AG, one of the world,s largest chemical companies. The ... operation with a focus on producing high-quality active pharmaceutical ... In connection with the sale of the site, the ...
Cached Medicine Technology:ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 2ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 4
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... Healthpointe is ... its La Tijera Clinic in Los Angeles. Licensed to practice Chinese Needle Therapy since ... on neuromuscular injuries and diseases. Dr. Priebe also practices in Healthpointe’s La Mirada clinic ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Banc Intranets ... Clear System. The agreement will enable both Johnson City, Tenn.-based firms to work synergistically ... is a cloud-based safety product that caters to organizations in the financial, commercial and ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue in ... 2016. The new facility will be located at US Highway 19 North and Highlands Boulevard, ... August 18, and work on the project is slated to begin in September 2015. ...
(Date:8/27/2015)... ... August 27, 2015 , ... Since its launch on August ... twelve offices in three counties, LA, Orange and San Bernardino. Their twenty ... Founded by Dr. Richy Agajanian, the Oncology Institute of Hope and Innovation is ...
(Date:8/27/2015)... ... August 27, 2015 , ... "I need a little help supporting and ... inventor from Camp Hill, Pa. "I developed this support handle to give me the ... AND SHOWER GRIP to provide a helping hand when stepping into or out of ...
Breaking Medicine News(10 mins):Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:Inventor and InventHelp Client Develops Bathroom Stabilization Aid (LCC-432) 2
... predict the risk of heart attack or death for patients ... ,Researchers conducted a study to determine whether blood levels ... or non-fatal heart attack in patients with acute chest pain. ... and it acts as an instigator of hardening and narrowing ...
... shows people who suffer from migraine headaches may be at ... of the brain where the tissue has died. ... 60. They grouped the patients into categories of having migraines ... A control group was also included in the study. Participants ...
... the cause of 90 percent of the world’s lung ... of cigarettes they smoke per day are exposed to ... agent. However, the reduction in the amount or concentration ... proportional to the reduction in cigarettes smoked. ,Researchers ...
... the drugs memantine and donepezil may improve // memory ... than 300 patients with moderate to severe Alzheimer’s. Participants ... began. Donepezil works by preventing the breakdown of acetylcholine, ... for memory and other thinking skills.For the study, patients ...
... Nearly 7 million patients suffering from chronic angina report ... two to three times more frequently than the general ... attacks despite current treatments, such as myocardial revascularization -- ... heart and is done largely to prevent angina -- ...
... could be significantly lowered by taking simple precautions // say ... studies in 20 centers in Europe, looking at 60 variables ... healthy infants to identify risks for SIDS. ,About 48 ... in the side or prone position. Around 16 percent of ...
Cached Medicine News:Health News:Reducing Number Of Cigarettes Not Enough 2Health News:New Medication May Decrease The Frequency Of Angina Attacks 2
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... feature 20 bipolar-spaced electrodes along a ... of mapping resolution in atrial fibrillation ... 20-pole catheter enables more accurate pinpointing ... 10-pole catheter systems. The result: greater ...
Livewire TC steerable ablation catheters are designed for the RF ablation of arrhythmias. They are available in a variety of curves and configurations, including bi-directional catheters for added fl...
Medicine Products: